Boothbay Fund Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,392
Closed -$272K 2236
2025
Q4
$272K Buy
+8,392
New +$359K ﹤0.01% 1494
2024
Q3
Sell
-27,071
Closed -$547K 1747
2024
Q2
$547K Buy
+27,071
New +$450K 0.01% 964
2023
Q4
Sell
-29,203
Closed -$184K 1784
2023
Q3
$184K Buy
29,203
+14,718
+102% +$109K ﹤0.01% 1455
2023
Q2
$136K Sell
14,485
-796,830
-98% -$7.9M ﹤0.01% 1561
2023
Q1
$8.05M Buy
811,315
+677,240
+505% +$5.93M 0.17% 117
2022
Q4
$859K Buy
134,075
+39,706
+42% +$226K 0.02% 966
2022
Q3
$527K Buy
94,369
+26,312
+39% +$159K 0.01% 1200
2022
Q2
$308K Buy
+68,057
New +$290K 0.01% 1448
2020
Q4
Sell
-136,238
Closed -$1.6M 1306
2020
Q3
$1.6M Buy
+136,238
New +$1.45M 0.1% 277

Other funds holding HIMS

Boothbay Fund Management's HIMS Position: Q1 2026 in Review

Boothbay Fund Management sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 8,392 shares — an estimated $272K sold.

Boothbay Fund Management first reported a position in HIMS in Q3 2020 and held it in 9 quarters. The position peaked at $8.05M in Q1 2023. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Boothbay Fund Management reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 8,392 Hims & Hers Health shares in Q1 2026, an estimated $272K.
  • Boothbay Fund Management first reported a position in Hims & Hers Health in Q3 2020 and held it in 9 quarters.
  • Boothbay Fund Management's Hims & Hers Health position peaked at $8.05M in Q1 2023.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.